20 Microns Limited (20MICRONS)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2 FY27 consolidated revenue 238.16 Cr, +3.2% y-y; EBITDA 27.73 Cr, margin 11.6%
- CapEx ₹100 Cr underway; 30% deployed including solar and mines; solar commissioning Q4 FY27
- Solar plant to meet 40% power needs, annual EBITDA benefit ~₹8 Cr from FY28
- Mining acquisitions to start production Dec 2026, enhancing raw material control
- Specialty products growing; value-added products contribute ~1/3 revenue, margins to improve as costs stabilize
- Imports ~40% of raw materials; local mines and imports serve different product sets
- 18% CAGR targeted over next 2-3 years; margin expansion includes solar benefits
- New product capacities in calcium carbonate, kaolin, talc, nano additives being expanded
- Exploring advanced materials for semiconductors, REPM under PLI scheme; timelines uncertain
- No buyback plans; promoter stake increase under consideration
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 20MICRONS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add 20MICRONS to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on 20 Microns Limited
Important.
The summary above is generated automatically from 20 Microns Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.